@ARTICLE{
author={Robinson Michael F,Damjanov Nemanja S,Stamenkovic Bojana N,Radunovic Goran L,Kivitz Alan J,Cox Lori,Manukyan Zorayr,Banfield Christopher,Saunders Michael,Chandra Deepa,Vincent Michael S,Mancuso Jessica,Peeva Elena,Beebe Jean S},
year={2020},
title={Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={10},
pages={1621-1631},
document_type={Article},
} 

@ARTICLE{
author={Robinson Michael F,Damjanov Nemanja S,Stamenkovic Bojana N,Radunovic Goran L,Kivitz Alan J,Cox Lori,Manukyan Zorayr,Banfield Christopher,Saunders Michael,Chandra Deepa,Vincent Michael S,Mancuso Jessica,Peeva Elena,Beebe Jean S},
year={2020},
title={Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={10},
pages={1621-1631},
document_type={Article},
} 

@ARTICLE{
author={Fleischmann Roy M,Damjanov Nemanja S,Kivitz Alan J,Legedza Anna,Hoock Thomas,Kinnman Nils},
year={2015},
title={A Randomized, Double-Blind, Placebo-Controlled, Twelve-Week, Dose-Ranging Study of Decernotinib, an Oral Selective JAK-3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={67},
number={2},
pages={334-343},
document_type={Article},
}